Screening of carbamazepine-saccharin (CBC-SAC) co-crystal by Nur Amanina, Mohamad Adaris
  
 
 
 
 
SCREENING OF CARBAMAZEPINE-SACCHARIN  
(CBC-SAC) CO-CRYSTAL 
 
 
 
 
 
 
 
NUR AMANINA BINTI MOHAMAD ADARIS 
 
 
 
 
 
 
 
BACHELOR OF CHEMICAL ENGINEERING 
UNIVERSITI MALAYSIA PAHANG 
  
 
 
 
SCREENING OF CARBAMAZEPINE-SACCHARIN  
(CBZ-SAC) CO-CRYSTAL 
 
 
 
 
 
NUR AMANINA BINTI MOHAMAD ADARIS 
 
 
 
 
 
Thesis submitted in partial fulfilment of the requirements  
for the award of the degree of 
Bachelor of Chemical Engineering 
 
 
 
 
Faculty of Chemical & Natural Resources Engineering 
UNIVERSITI MALAYSIA PAHANG 
 
 
 
 
JUNE  2017 
 
ii 
 
 
 
SUPERVISOR’S DECLARATION 
 
We hereby declare that we have checked this thesis and in our opinion, this thesis is 
adequate in terms of scope and quality for the award of the degree of Bachelor of 
Chemical Engineering. 
  
 
 
Signature    :  
Name of main supervisor : DR. SYARIFAH BINTI ABDUL RAHIM 
Position   : LECTURER 
Date    : JUNE 2017 
 
 
iii 
 
 
 
STUDENT’S DECLARATION 
 
I hereby declare that the work in this thesis is my own except for quotations and 
summaries which have been duly acknowledged. The thesis has not been accepted for 
any degree and is not concurrently submitted for award of other degree 
 
 
Signature : 
Name  : NUR AMANINA BINTI MOHAMAD ADARIS 
ID Number : KA13112 
Date  : JUNE 2017 
 
  
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to humanity. 
 
 
  
v 
 
 
ACKNOWLEDGEMENT 
 
I would like to express my special appreciation and thanks to my supervisor, Dr. 
Syarifah Binti Abdul Rahim. You have been patience and a brilliant mentor for me. I 
would like to thank you for your never ending support during my tenure as research 
student under your guidance, for giving insightful comments and suggestions of which 
without it, my research path would be a difficult one . Your advice on my research has 
been valuable.  
 
A special thanks to my family. Words cannot express how grateful I am to my 
mother and father. Your prayer for me was what sustained me thus far. Both of you 
always be my support in the moments when there was no one to answer my queries and 
for all the sacrifices you have made on my behalf. 
 
I am also indebted to the Ministry of Higher Education and University Malaysia 
Pahang for funding my study. 
 
I would also like to thank all of my friends who supported me in writing, and 
motivate me to strive towards my goal. I am sincerely grateful to the staffs of Chemical 
Engineering and Natural Resources Faculty who helped me in many ways and made my 
stay in UMP pleasant and unforgettable. 
 
  
viii 
 
 
TABLE OF CONTENTS 
           Page 
SUPERVISOR’S DECLARATION ii 
STUDENT’S DECLARATION iii 
ACKNOWLEDGEMENT v 
ABSTRACT vi 
ABSTRAK vii 
TABLE OF CONTENTS viii 
LIST OF TABLES x 
LIST OF FIGURES xi 
LIST OF SYMBOLS xiii 
LIST OF ABBREVIATIONS xiv 
CHAPTER 1 INTRODUCTION 1 
1.1 Background of the Study 1 
1.2 Motivation 2 
1.3 Problem Statement 2 
1.4 Objective 3 
1.5 Scopes of Study 3 
1.6 Report Layout 4 
1.7 References 5 
CHAPTER 2 LITERATURE REVIEW 6 
2.1 Chapter Overview 6 
2.2 Co-crystal Background Review 6 
2.2.1 Co-crystal Definition 6 
2.2.2 Understanding Co-crystal 9 
2.2.3 Co-crystal Engineering 13 
2.2.4 Pharmaceutical Co-crystal Design Strategies 14 
2.2.5 Co-crystal Formation Method 16 
2.2.6 Co-crystal Characterization Technique 19 
2.2.7 Type of Crystal Geometry 21 
2.2.8 Physicochemical Properties of Co-crystal 22 
2.3 Carbamazepine (CBZ) Co-crystal Studies 24 
2.3.1 CBZ Introduction 24 
2.4 Carbamazepine-Saccharin (CBZ-SAC) Co-crystal 25 
2.5 Definition of basic pharmaceutical physical chemistry 27 
2.6 References 30 
ix 
 
 
CHAPTER 3 METHODOLOGY 34 
3.1 Chapter Overview 34 
3.2 Materials 34 
3.3 Experimental 35 
3.3.1 Preparation of Carbamazepine-Saccharin (CBZ-SAC) Co-crystal 35 
3.3.2 Cooling Crystallization Method 36 
3.3.3 Solvent Evaporation Method 37 
3.3.4 Slurry Method 37 
3.3.5 Stirring Method 38 
3.4 Analytical Instruments 39 
3.4.1 Characterization Analysis 39 
3.5 References 41 
CHAPTER 4 RESULTS AND DISCUSSION 42 
4.1 Introduction 42 
4.2 X-ray Powder Diffraction (XRPD) 42 
4.3 Differential Scanning Calorimetry (DSC) 46 
4.4 Fourier Transform Infrared (FTIR) 49 
4.5 Optical Microscopic 51 
4.6 References 56 
CHAPTER 5 CONCLUSION AND RECOMMENDATION 57 
COMPILED REFERENCES 58 
 
 
 
 
  
x 
 
 
LIST OF TABLES 
 
Table No.      Title       Page 
 
Table 2. 1: Literature definitions of co-crystal 7 
Table 2. 2: Characterization Technique 19 
Table 2. 3: Carbamazepine solubility, (Kasim et. al., 2003) 22 
Table 2. 4: Type of solubility, (Kasim et. al., 2003) 23 
Table 2. 5: XPRD analysis data 25 
Table 3. 1: Chemical details 34 
Table 4. 1: Summary result for co-crystal formation         45 
Table 4. 2: DSC analysis result 46 
Table 4. 3: Optical microscopic analysis of co-crystal 53 
  
xi 
 
 
LIST OF FIGURES 
 
Figure No.      Title       Page 
 
Figure 2. 1: Possible multicomponent system along with their respective 
solvate/hydrate forms 8 
Figure 2. 2: Classification of API solid form based on molecular structure 9 
Figure 2. 3: Multi-components crystals 10 
Figure 2. 4: Common solid state and their respected components 11 
Figure 2. 5: Salt (left) and co-crystal (right) 12 
Figure 2. 6: Typical hydrogen bonds utilized in crystal engineering 13 
Figure 2. 7: Supramolecular synthons observed in co-crystal 14 
Figure 2. 8: Steps for co-crystal design and preparation 15 
Figure 2. 9: Break down of techniques used for co-crystallization in open literature, 
(Sheikh et. al., 2003) 16 
Figure 2. 10: Concept of Co-crystallization from Solvent Mixtures to prevent solvate 
formation 19 
Figure 2. 11: Carbamazepine molecular structure 24 
Figure 2. 12 : Carbamazepine: Saccharin (1:1) co-crystal components and schematics 
packing motif in methanol solution, (Hickey et.al.,2007) 25 
Figure 2. 13: PXRD pattern of CBZ-SAC I & CBZ-SAC II 26 
Figure 2. 14 : Biopharmaceutics classification system (BSC) 28 
Figure 4. 1: XRPD for the pure component SAC and CBZ 43 
Figure 4. 2: XPRD for solid form in formic acid (FRA) solvent 43 
Figure 4. 3:XPRD for solid form in ethyl acetate (EA) solvent 44 
Figure 4. 4: DSC analysis for pure component of CBZ 46 
Figure 4. 5: DSC analysis for pure component of SAC 47 
Figure 4. 6: DSC analysis for CBZ-SAC Form I co-crystal 48 
Figure 4. 7: DSC analysis for CBZ-SAC Form II co-crystal 48 
Figure 4. 8: FTIR for pure component CBZ 49 
Figure 4. 9: FTIR for pure component SAC 50 
Figure 4. 10: FTIR for CBZ-SAC Form I 50 
Figure 4. 11: FTIR for CBZ-SAC Form II 51 
Figure 4. 12: Stirring method morphology 52 
xii 
 
 
Figure 4. 13: Slurry method morphology 52 
 
 
xiii 
 
 
LIST OF SYMBOLS 
 
°C Celsius 
D◦ Dose number 
° Degree 
𝜌 Density 
> Higher than 
μ Micro 
% Percentage  
pKa                     Index to express acidity of the week acid 
θ Theta 
  
xiv 
 
 
 
LIST OF ABBREVIATIONS 
 
API Active Pharmaceutical Ingredient 
BSC Biopharmaceutics Classification System 
CBZ Carbamazepine 
CBZ-SAC Carbamazepine-Saccharin Co-crystal 
CCF Co-crystal Former 
CSD Cambridge Structural Database 
DSC Differential Scanning Calorimetric 
EA Ethyl Acetate 
FRA Formic Acid 
FS Freely soluble 
FTIR Fourier Transform Infrared Spectroscopy 
GRAS Generally Recognized As Safe 
HPLC High-Performance Liquid Chromatography  
IR Infrared Spectroscopy 
NCT Nicotinamide 
NCT-SAC Nicotinamide-Saccharin 
RC Reaction Co-crystallisation 
PI Practically insoluble 
S Soluble 
SAC Saccharin 
SEM Scanning Electron Microscopy 
SPS Sparingly soluble 
SS Slightly soluble 
SSNMR Solid State Nuclear Magnetic Resonance Spectroscopy 
xv 
 
 
 
SXRD Single Crystal X-ray Diffraction 
TGA Thermogravimetric Analysis 
VS Very soluble 
XRPD X-ray Powder Diffraction 
VSS Very slightly soluble 
